Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index98
i10-index354
Publications975
Citations46,740

Grants

9 total · 2 active

NIH #P30CA016058

Project 05: Translational Therapeutics (TT)

Active
Amount
<$100K
Period
1997-09-12 → 2031-03-31
PIs
1

Awarded at OHIO STATE UNIVERSITY

NIH #R01CA248741

Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer

Active
Amount
$700K–$800K
Period
2021-02-01 → 2027-01-31
PIs
2

Awarded at OHIO STATE UNIVERSITY

NIH #UG1CA233331

OSU as a Network Lead Academic Participating Site for the NCI NCTN

Amount
$1M–$2M
Period
2019-03-28 → 2026-02-28
PIs
5

Awarded at OHIO STATE UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

9 total · 2 active

NIH #P30CA016058

Project 05: Translational Therapeutics (TT)

Active
Amount
<$100K
Period
1997-09-12 → 2031-03-31
PIs
1

Awarded at OHIO STATE UNIVERSITY

NIH #R01CA248741

Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer

Active
Amount
$700K–$800K
Period
2021-02-01 → 2027-01-31
PIs
2

Awarded at OHIO STATE UNIVERSITY

NIH #UG1CA233331

OSU as a Network Lead Academic Participating Site for the NCI NCTN

Amount
$1M–$2M
Period
2019-03-28 → 2026-02-28
PIs
5

Awarded at OHIO STATE UNIVERSITY

NIH #UG1CA233259

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$800K–$900K
Period
2019-03-14 → 2025-02-28
PIs
3

Awarded at EMORY UNIVERSITY

NIH #R01CA175370

Notch ligands in regulation of anti-cancer immunity

Amount
$300K–$400K
Period
2013-09-26 → 2018-08-31
PIs
2

Awarded at OHIO STATE UNIVERSITY

NIH #U54CA163072

Clinical Trials Core

Amount
$200K–$300K
Period
2011-09-23 → 2016-08-31
PIs
2

Awarded at VANDERBILT UNIVERSITY

NIH #U01CA114771

Molecular Signatures of Lung Cancer

Amount
$1M–$2M
Period
2005-09-30 → 2012-08-31
PIs
1

Awarded at VANDERBILT UNIVERSITY

NIH #RC1CA146260

Polymorphism and mutation spectrum in minorities with non-small cell lung cancer

Amount
$300K–$400K
Period
2009-09-30 → 2012-08-31
PIs
1

Awarded at VANDERBILT UNIVERSITY

NIH #P50CA090949

SPORE in Lung Cancer

Amount
$2M–$3M
Period
2001-06-28 → 2012-03-31
PIs
1

Awarded at VANDERBILT UNIVERSITY

Recent Public Signals

  1. New paper: Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (Clinical Cancer Research)2026-06-26
  2. New preprint: <i>Candida albicans</i> infiltrates colon and rectal cancers causing therapeutic resistance and decreased survival2025-09-21
  3. New NIH award: Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer2021-02-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-3002-1921

Professor Insights

Career Trajectory